Consensus Hansa Biopharma AB Mexican S.E.

Equities

HNSA N

SE0002148817

End-of-day quote Mexican S.E. Other stock markets 07:00:00 2023-03-15 pm EDT			5-day change	1st Jan Change
160.8 ^MXN	-.--%		-.--%	-.--%

Jun. 27	Hansa Biopharma AB Announces Board Appointments	CI
May. 31	Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial	MT

Evolution of the average Target Price on Hansa Biopharma AB

Price target over the last 5 years

History of analyst recommendation changes

1deeeafcce485475aa1bd5f49a1.2lINmyK4GZKjpuJJGw5nTYNpA_oxR_6ICgO1a_LVvXg.jyd-o03-YevPztYgeWA4BsAbRrZwA8q6ck_5G72f9EztGXzOaOk0xJDuiQ~a63f5ca57f2d96eab33c5cf76f6dcf53